Immunocore (IMCR)

28.89

-0.48 (-1.63%)

At close: Mar 03, 2025, 3:59 PM

28.88

-0.02%

After-hours: Mar 03, 2025, 04:00 PM EST

Immunocore Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-51.09M	-43.37M	-41.22M	-131.52M	-74.09M	-103.93M	-71.63M
Depreciation & Amortization	4.2M	4.09M	6.13M	7.01M	8.98M	9.21M	6.71M
Stock-Based Compensation	34.19M	32.47M	32.89M	48.89M	8.16M	3.06M	666K
Other Working Capital	50.2M	5.78M	19.2M	-11.66M	-28.27M	-11.92M	67.58M
Other Non-Cash Items	-6.38M	3.97M	-7.42M	-14.89M	38.45M	22.64M	-3.4M
Deferred Income Tax	n/a	n/a	-2.92M	-9.4M	-13.27M	-22.26M	-16.55M
Change in Working Capital	45.13M	5.78M	-12.88M	-16.81M	-28.8M	-10.09M	67.58M
Operating Cash Flow	26.06M	2.94M	-31.27M	-129.75M	-60.57M	-101.38M	-16.63M
Capital Expenditures	-5.17M	-5.42M	-2.2M	-1.01M	-3.07M	-4.28M	-3.54M
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-350M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	27.45M
Other Investing Acitivies	44K	-1.17M	2.43M	513K	3.54M	139K	34.1M
Investing Cash Flow	-355.13M	-5.42M	233K	-495K	467K	-4.14M	58.01M
Debt Repayment	352.5M	n/a	n/a	n/a	45.13M	-4.04M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-8.62M	34.35M	-1.29M	-10.63M	-145.23K	-711K	101K
Financial Cash Flow	343.88M	34.35M	138.23M	276.25M	115.94M	55.13M	101K
Net Cash Flow	13.11M	40.15M	114.31M	146.03M	55.75M	-50.42M	41.5M
Free Cash Flow	20.89M	-2.48M	-33.47M	-130.76M	-63.65M	-105.65M	-20.16M